1122 search results for:

CYTENA, a BICO group company and a leading provider of high-precision instruments for handling biological cells, has entered a collaboration agreement with ExcellGene SA, a leading biologics Contract Development & Manufacturing Organization (CDMO) that manufactures recombinant proteins. Together, the companies will streamline cell line development workflows for highly-efficient monoclonal antibody (mAb) and complex therapeutic protein […]

KNAUER Wissenschaftliche Geräte, a developer of laboratory instruments and known for their liquid chromatography systems and components, was honoured with the German Innovation Award 2022 in Munich in April for their design and manufacture of large-scale plants, at its own risk, for the ncapsulation of mRNA for COVID-19 vaccines. Equipment for the production of millions of mRNA vaccine doses had […]

Agilent Technologies says its PD-L1 IHC 22C3 pharmDx, Code SK006, is now EU CE-IVD–marked for use in cervical cancer. PD-L1 IHC 22C3 pharmDx can be used as an aid in identifying cervical cancer patients for whom treatment with KEYTRUDA (pembrolizumab) may be appropriate. 

Avacta Group, a clinical stage oncology drug company developing cancer therapies and diagnostics based on its proprietary pre|CISION and Affimer platforms, has relocated its Therapeutics division to a new headquarters at Scale Space, in Imperial College’s White City Campus, London.